文献速递儿童青少年精神

铜蓝蛋白缺乏驱动梭状回脂质-髓鞘共病构成孤独症视觉亚型

Ceruloplasmin deficiency drives a fusiform-centric lipid-myelin pathology underlying a visual subtype in autism.
PubMed 文献 · Mol Psychiatry · 2026-04-17

该研究整合多模态MRI与血清铁、铅、铜蓝蛋白检测,在288名儿童(含90例伴非典型视觉加工的ASD、89例不伴该特征的ASD及109名TD儿童)中探索脂质与髓鞘机制。ASD-AVP亚组表现出以梭状回为中心的脂质与髓鞘升高共病及独特正相关,血清铜蓝蛋白降低、铁降低、铅升高,中介分析提示铜蓝蛋白缺乏经脂质通路影响梭状回髓鞘化(35%-55%)。梭状回脂质-髓鞘联合特征可强区分ASD-AVP与TD(AUC=0.93)及ASD-nAVP(AUC=0.87)。

要点

  • ASD-AVP亚组存在以梭状回为中心的脂质与髓鞘升高共病。
  • 血清铜蓝蛋白降低经脂质通路介导梭状回髓鞘化改变(35%-55%)。
  • 梭状回脂质-髓鞘联合特征区分ASD-AVP与TD的AUC为0.93。

核心结论

  • 铜蓝蛋白缺乏驱动的梭状回脂质-髓鞘共病是孤独症视觉亚型的特异性机制,并可作为生物分型与靶向干预的候选标志物。

研究设计与样本

  • 整合多模态MRI定量74个核团或脑区的脂质(质子密度脂肪分数)与髓鞘含量(合成MRI),并检测288名儿童血清铁、铅和铜蓝蛋白。
  • 纳入90例伴非典型视觉加工的ASD(ASD-AVP)、89例不伴该特征的ASD(ASD-nAVP)及109名典型发育(TD)儿童。
  • 采用BTBR AVP样与nAVP样小鼠模型验证表型,并对部分患者进行初步纵向随访。

主要发现

  • ASD-AVP亚组表现出以梭状回为中心的脂质与髓鞘升高共病,并呈独特正相关(左侧r=0.47,右侧r=0.41)。
  • ASD-AVP血清铁和铜蓝蛋白降低、铅升高,中介分析提示铜蓝蛋白缺乏经脂质通路影响梭状回髓鞘化(35%-55%)。
  • BTBR AVP样小鼠重现髓鞘过度增生且结构紊乱,nAVP样小鼠则表现为髓鞘低下。
  • 梭状回脂质-髓鞘联合特征区分ASD-AVP与TD的AUC=0.93,区分ASD-AVP与ASD-nAVP的AUC=0.87。
  • 初步纵向随访显示血清铜蓝蛋白改善与梭状回脂质含量降低、髓鞘稳定及临床改善平行。

关键数值与推荐

  • ASD-AVP组梭状回脂质-髓鞘正相关:左侧r=0.47,右侧r=0.41。
  • 铜蓝蛋白缺乏经脂质通路影响梭状回髓鞘化的中介比例为35%-55%。
  • 梭状回脂质-髓鞘联合特征区分ASD-AVP与TD的AUC=0.93,区分ASD-AVP与ASD-nAVP的AUC=0.87。

临床怎么用

  • 对ASD伴非典型视觉加工者,可关注血清铜蓝蛋白、铁、铅及梭状回脂质-髓鞘影像特征作为生物亚型分型参考。
  • 血清铜蓝蛋白改善与梭状回脂质降低、髓鞘稳定及临床改善平行,提示其作为随访监测指标的潜在价值。

局限性

  • 纵向随访仅在部分患者中进行,属初步结果。
  • 中介分析提示的脂质通路机制仍需进一步实验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Atypical visual processing (AVP) commonly occurs in autism spectrum disorder (ASD) and contributes to social impairments, yet its neurobiological basis remains poorly characterized. To investigate potential lipid and myelin mechanisms, this study integrated multimodal MRI, quantifying lipid (proton density fat fraction) and myelin content (synthetic MRI) of 74 nuclei or brain regions, with serum profiling of iron, lead, and ceruloplasmin in 288 children, including 90 ASD with atypical visual processing (ASD‑AVP), 89 ASD without atypical visual processing (ASD‑AVP), and 109 typically developing (TD). The ASD-AVP subgroup exhibited a distinct co-pathology of elevated lipid and myelin centered on the fusiform gyrus (FG), accompanied by a unique positive lipid-myelin correlation (left: r = 0.47, right: r = 0.41). Serum analyses revealed decreased iron and ceruloplasmin and increased lead in ASD-AVP, and mediation analysis indicated that ceruloplasmin deficiency influences FG myelination via lipid pathways (35%-55%). Crucially, BTBR AVP-like mice recapitulated this phenotype with disorganized hypermyelination, whereas nAVP-like mice showed hypomyelination. A combined FG lipid-myelin signature strongly distinguished ASD-AVP from TD (AUC = 0.93) and ASD-nAVP (AUC = 0.87). Preliminary longitudinal follow-up in a subset of patients revealed that improvement in serum ceruloplasmin was associated with a reduction in FG lipid content and stabilization of myelin, paralleling clinical improvement. These findings identify a ceruloplasmin-driven, FG-centric lipid-myelin co-pathology, representing a maladaptive "inflammatory pseudo-compensation" mechanism specific to a visual ASD subtype, and offer novel biomarkers for biological subtyping and targeted interventions.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Deng YY, Zhong SS, Wang SH, et al. Ceruloplasmin deficiency drives a fusiform-centric lipid-myelin pathology underlying a visual subtype in autism. Mol Psychiatry. 2026. PMID: 41998191. doi:10.1038/s41380-026-03613-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。